Amin Talebi Bazmin Abadi
Assistant Professor
Speciality: Bacteriology
  • BS/BA: Biology
  • MS: Medical Bacteriology
  • PhD: Medical Bacteriology
  • Phone: 82884883
  • Fax:
  • Email: Amin.talebi@modares.ac.ir
    • Address: ​Tarbiat Modares University, Dept of Bacteriology
  • Resume Download
 

Name: Amin

 

Last name: Talebi Bezmin Abadi                    

 

Email: Amin.talebi@modares.ac.ir; Amin.talebi@gmail.com

 

Birthday: 4th December 1983

 

Birth Place: Sari, Mazandaran Province, Iran

 

B.S: Biology, University of Golestan, Gorgan, Iran, 2005.

 

M.S: Medical Bacteriology, University of Tarbiat Modares, Tehran, Iran, 2009.  

 

PhD: Medical Bacteriology, Utrecht University, Utrecht, the Netherlands, 2013.

 
 

Work interest:

 

 - Investigation of novel virulence factors of Helicobacter pylori in clinical isolates

 

- Treatment of Helicobacter pylori: new regimens and management of the infection

 

 

 

Reviewer in the journals:

Journal of Medical Microbiology

 

Japanese Journal of Infectious Diseases

 

Journal of Infection and Public Health

 

Govaresh

 

African Journal of Microbiology Research

 

Microbiology Research International

 

J Global Infectious Diseases

 

Annual Research & Review in Biology

 

Saudi Journal of Gastroenterology

 

 Editorial board:

 

Journal of Clinical Gastroenterology and Hepatology

 

 

 

Book chapters:

 

 

 

1.  Helicobacter pylori: A Worldwide Perspective 2014, Chapter (1). Publisher: Bentham Science Publishers, Oak Park, IL USA., Editor: Buzás György Miklós. Main Bacteriological Features of Helicobacter pylori. Amin Talebi Bezmin Abadi, Johannes G. Kusters. Year: 2014; Pages 1-10;  ISBN: 78-1-60805-738-2.

 

 2.  Helicobacter pylori: A Worldwide Perspective 2014, Chapter (10). Publisher: Bentham Science Publishers, Oak Park, IL USA., Editor: Buzás György Miklós. Helicobacter pylori Infection in Iran: Epidemiology, Treatment and Diagnosis.  Amin Talebi Bezmin Abadi, Johannes G. Kusters. Year: 2014; Pages 216-233; ISBN: 978-1-60805-738-2.

 

 

Publications:

 

 

1.      Talebi Bezmin Abadi A, Lee Yeh Y. Helicobacter pylori vacA as marker for gastric cancer and gastroduodenal diseases: One but not the only factor. Journal of Clinical Microbiology. 2014. (In press).

 

 2.         Talebi Bezmin Abadi A, Lee Y. Inverse correlation between Helicobacter pylori and obesity–a conclusion too early? Alimentary pharmacology & therapeutics. 2014; 40(9):1119-1112.

 

 3.         Talebi Bezmin Abadi A, Mohabbati Mobarez A. High prevalence of Helicobacter pylori hopQ II genotype isolated from Iranian patients with gastroduodenal disorders. Journal of pathogens. 2014;2014.

 

 4.         Talebi Bezmin Abadi A. Type 2 diabetes and Helicobacter pylori infection: Starting point for the reality? Indian Journal of Endocrinology and Metabolism. 2014. (In press).

 

5.         Talebi Bezmin Abadi A. Helicobacter pylori: Emergence of a Superbug. Frontiers Medicine; Infectious Diseases. 2014;1:34.

 

6.         Talebi Bezmin Abadi A. Helicobacter pylori: A Beneficial Gastric Pathogen? Frontiers Medicine; Gastroenterology. 2014;1:26.

 

7.         Talebi Bezmin Abadi A. The Helicobacter pylori dupA: A Novel Biomarker for Digestive Diseases. Frontiers Medicine; Infectious Diseases. 2014;1:13.

  

8.         Talebi Bezmin Abadi A. Therapy of Helicobacter pylori: Present Medley and Future Prospective. BioMed Research International. 2014;2014:7.

 

9.         Talebi Bezmin Abadi A. Novel idea: virulence-based therapy against Helicobacter pylori infection (smart therapy). Frontiers Medicine; Gastroenterology. 2014;1(18):1-2.

10.       Talebi Bezmin Abadi A, et al. Virulent Helicobacter pylori in dental plaque and gastric specimen samples. Journal of Clinical Gastroenterology and Hepatology. 2014;1(1):1-4.

 11.       Talebi Bezmin Abadi A, et al. First case of Helicobacter pylori infection resistant to seven antibiotics in Iran. Journal of the Brazilian Society of Tropical Medicine. 2014:3.

 

12.       Talebi Bezmin Abadi A, et al. Concomitant colonization of Helicobacter pylori in dental plaque and Gastric biopsy. Journal of pathogen. 2014.

 

13.       Talebi Bezmin Abadi A, et al. Clinical relevance of the cagA, tnpA and tnpB genes in Helicobacter pylori. BMC Gastroenterology. 2014;14(3).

 

14.       Talebi Bezmin Abadi A, Loffeld RJ, Constancia AC, Wagenaar JA, Kusters JG. Detection of the Helicobacter pylori dupA gene is strongly affected by the PCR design. Journal of Microbiological Methods. 2014;106:55-56.

 

15.       Talebi Bezmin Abadi A, Taghvaei T. Virulence of Helicobacter pylori: Yesterday, today and tomorrow. Medical Laboratory Journal. 2014; 8(1):82-90.

 

16.       Talebi Bezmin Abadi A. Virulence Factors of Helicobacter pylori: Practical biomarkers. Recent Patents on Biomarkers. 2014;4(3):4.

 

17.       Talebi Bezmin Abadi A. Helicobacter pylori Infection in Iran: A new perspective. Journal of Gastroenterology and Hepatology Research. 2014;3(8).

 

18.       Talebi Bezmin Abadi A. Helicobacter pylori Infection: Protective agent against Mycobacterium tuberculosis. Journal of Clinical Gastroenterology and Hepatology. 2014;1(2):1-2.

 

19.       Talebi Bezmin Abadi A. Mix Infections of Helicobacter pylori: A major risk factor affecting genotyping studies. International Journal of Bacteriology. 2014;2014:1.

 

20.       Talebi Bezmin Abadi A, Mobarez AM. Conclusive strategies for therapy and virotyping of Helicobacter pylori. Saudi Journal of Gastroenterology. 2014;20(5):325-326.

 

21.       Ajami A, Shadman M, Rafiei A, Hosseini V, Talebi Bezmin Abadi A, Alizadeh A, et al. Prevalence of EPIYA motifs in Helicobacter pylori strains isolated from patients with gastroduodenal disorders in northern Iran. Research in Molecular Medicine. 2013;1(1):30-35.

 

22.       Talebi Bezmin Abadi A, et al. Biomarker in Helicobacter pylori infection: the standoff condition? Journal of the Brazilian Society of Tropical Medicine. 2013;46(4):529-530.

 

23.       Talebi Bezmin Abadi A, Taghvaei T, Mobarez AM, Vaira G, Vaira D. High correlation of babA2-positive strains of Helicobacter pylori with the presence of gastric cancer. Internal and Emergency Medicine. 2013;8(6):497-501.

 

24.       Talebi Bezmin Abadi A, Ghasemzadeh A, Mobarez AM. Low frequency of cagA-positive Helicobacter pylori strains isolated from Iranian patients with MALT lymphoma. Internal and Emergency Medicine. 2013;8(1):49-53.

 

25.       Talebi Bezmin Abadi A, Bonten MJ, Kusters JG. Comment to:“Different Antibiotic No Culture Eradication (DANCE) of Helicobacter pylori: An easy way to manage H. pylori eradication”. Digestive and Liver Disease. 2013;45(5).438-439.

 

26.       Talebi Bezmin Abadi A, Mobarez AM. Helicobacter pylori in the era of probiotics: A controversial application. Saudi Journal of Gastroenterology. 2013;19(5):240-241.

 

27.       Talebi Bezmin Abadi A, Kusters JG. Association of inducible nitric oxide synthetase genotype and Helicobacter pylori infection gastric cancer risk may be due to faulty primer design. World J Gastroenterol. 2013;19(3):429-430.

 

28.       Taghvaei T, Talebi Bezmin Abadi A, Ghasemzadeh A, Naderi BK, Mobarez AM. Prevalence of horB gene among the Helicobacter pylori strains isolated from dyspeptic patients: first report from Iran. Internal and Emergency Medicine. 2012;7(6):505-508.

 

29.       Talebi Bezmin Abadi A, Johannes G, Kusters. Correct screeing the virulence genes in Helicobacter pylori. Govarsh. 2012;17(3):175-176.

30.       Talebi Bezmin Abadi A, Taghvaei T, Wolfram L, Kusters JG. Infection with Helicobacter pylori strains lacking dupA is associated with an increased risk of gastric ulcer and gastric cancer development. Journal of Medical Microbiology. 2012;61(1):23-30.

 

31.       Talebi Bezmin Abadi A, Ghasemzadeh A, Taghvaei T, Mobarez AM. Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. Internal and Emergency Medicine. 2012;7(5):447-452.

 

32.       Talebi Bezmin Abadi A, Taghvaei T, Wolfram L. Inefficiency of rapid urease test for confirmation of Helicobacter pylori. Saudi Journal of Gastroenterology. 2011;17(1):84-85.

 

33.       Talebi Bezmin Abadi A, Taghvaei T, Mobarez AM, Carpenter BM, Merrell DS. Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran. Journal of Microbiology. 2011;49(6):987-993.

 

34.       Talebi Bezmin Abadi A, et al. Helicobacter pylori homB, but not cagA, is associated with gastric cancer in Iran. Journal of Clinical Microbiology. 2011;49(9):3191-3197.

 

35.       Talebi Bezmin Abadi A, Taghvaei T, Ghasemzadeh A, Mobarez AM. High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran. Saudi Journal of Gastroenterology. 2011;17(6):396-399.

 

36.       Tomatari H, Mobarez AM, Amini M, Hosseini D, Talebi Bezmin Abadi A. Helicobacter pylori resistance to metronidazole and clarithromycin in dyspeptic patients in Iran. Iranian Red Crescent Medical Journal. 2010;12(4):409-412.

 

37.       Talebi Bezmin Abadi A, et al. An investigation of the prevalence of iceA genotypes in Helicobacter pylori strains isolated from peptic ulcer patients in Sari. Arak Medical University Journal. 2010;13(3):84-90.

 

38.       Talebi Bezmin Abadi A, Mobarez AM, Taghvaei T, Wolfram L. Antibiotic resistance of Helicobacter pylori in Mazandaran, North of Iran. Helicobacter. 2010;15(6):505-509.

 

39.       Talebi Bezmin Abadi A, Taghvaei T, Vaira D. Considerable use of furazolidone in Iran. Saudi Journal of Gastroenterology. 2010;16(4):308-309.

 

40.       Talebi Bezmin Abadi A, Mobarez A, Ajami A, Rafiee A, Taghwaii T. Evaluation on antibiotic resistance of Helicobacter pylori isolated from patients admitted to Tooba Medical Center, Sari. Journal of Mazandaran University of Medical Sciences. 2009;18(70). 26-32.